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Abstract
Formation of foam cell macrophages, which sequester extracellular modified lipids, is a key
event in atherosclerosis. How lipid loading affects macrophage phenotype is controversial,
with evidence suggesting either pro- or anti-inflammatory consequences. To investigate
this further, we compared the transcriptomes of foamy and non-foamy macrophages that
accumulate in the subcutaneous granulomas of fed-fat ApoE null mice and normal chow fed
wild-type mice in vivo. Consistent with previous studies, LXR/RXR pathway genes were sig-
nificantly over-represented among the genes up-regulated in foam cell macrophages.
Unexpectedly, the hepatic fibrosis pathway, associated with platelet derived growth factor
and transforming growth factor-β action, was also over-represented. Several collagen poly-
peptides and proteoglycan core proteins as well as connective tissue growth factor and
fibrosis-related FOS and JUN transcription factors were up-regulated in foam cell macro-
phages. Increased expression of several of these genes was confirmed at the protein level
in foam cell macrophages from subcutaneous granulomas and in atherosclerotic plaques.
Moreover, phosphorylation and nuclear translocation of SMAD2, which is downstream of
several transforming growth factor-β family members, was also detected in foam cell macro-
phages. We conclude that foam cell formation in vivo leads to a pro-fibrotic macrophage
phenotype, which could contribute to plaque stability, especially in early lesions that have
few vascular smooth muscle cells.
Introduction
Atherosclerosis, the underlying cause of many vascular diseases, can be considered to be a heal-
ing response to multiple injurious stimuli that include endothelial dysfunction, lipid retention
and inflammation (with activation of both innate and adaptive immune systems) [1,2]. Reten-
tion and oxidation of extracellular lipid in the vessel wall provokes the production of inflam-
matory mediators that recruit monocytes, which differentiate to macrophages [3,4]: it also
creates neo-epitopes that can activate the immune system. Modified extracellular lipid is then
taken up into foam cell macrophages (FCMs) [3] and smooth muscle cells (SMCs) [5,6]. Plaque
macrophages and FCMs may also be differentially activated, adopting pro-inflammatory
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phenotypes similar to those designated M1 or ‘classically activated’ from in vitro experiments
[7–9]. M1-like macrophages have been observed especially at the shoulder region of the fibrous
cap of plaques. They express higher levels of many proteases, including matrix metalloprotei-
nases (MMPs) [8], which can degrade the extracellular matrix leading to loss of collagen. This
promotes subsequent cap rupture, thrombus formation and hence life-threatening myocardial
infarctions or strokes [10,11]. Death of FCMs, because it releases lipid and enlarges the necrotic
core of the plaque, increases mechanical stress on the plaque cap [12] and further promotes
plaque rupture. Conversely, plaque macrophages with similarities to M2 or alternatively acti-
vated phenotypes have also been detected, especially in areas of plaques remote from the core,
and in the adventitia [3,9,13]. These include so-called M2a, M2c/Mreg, Mhem and Mox mac-
rophages that are anti-inflammatory, promote tissue repair and hence favour plaque stability
[3,4,14–16].
The role of lipid uptake and foam cell formation per se in the activation of macrophage
behaviour that provokes plaque rupture is controversial. Different in vitro studies suggested
pro- or anti-inflammatory effects of treatment with oxidised lipids, whereas others showed no
major influence on markers of M1 and M2 polarization [17–20]. Results from ex vivo studies
of FCMs generated in vivo are also conflicting. Rabbit FCMs purified from subcutaneous gran-
ulomas showed increased activation of the nuclear factor-κB (NF-κB) pathway and production
of several NF-κB dependent MMPs compared with non-foamy macrophages (NFMs) [21,22].
On the other hand, a recent paper that compared FCMs with NFMs isolated from the perito-
neum of atherosclerosis-prone mice suggested that increased desmosterol levels in FCMs initi-
ate a transcriptional programme mediated by the liver X receptor (LXR) that suppresses the
expression of many pro-inflammatory genes [23]. To re-examine this controversy, we adapted
the subcutaneous sponge model we used in rabbits [21,22] for use in mice, and compared the
transcriptomes of FCMs and NFMs produced in fat-fed ApoE null or wild-type mice. We then
validated the differential expression of selected genes at the protein level both in subcutaneous
granulomas and in brachiocephalic artery plaques.
We found, unexpectedly, that foam cell formation under these conditions favoured neither
M1 nor M2 polarization but instead induced a pro-fibrotic transcriptional programme that
should favour plaque stability. Understanding how FCMs are different from NFMs could
enhance our ability to treat or prevent atherosclerotic plaque development and subsequent
acute events.
Materials and Methods
Animals
The housing and care of all animals and procedures used in these studies was in accordance
with and under license of the Animals (Scientific Procedures) Act 1986 (London, United King-
dom), and conform to the Guide for the Care and Use of Laboratory Animals published by the
U.S. National Institutes of Health (Publication No. 85–23, revised 1996). The study received
local institutional review board (University of Bristol, Bristol, United Kingdom) approval.
Homozygous ApoE−/−mice and wild-type (control) mice on a C57BL background were bred
in the University of Bristol Animal Services Unit.
Surgical sponge implantation and harvest of foamy and non-foamy macrophages.
Adult male ApoE−/−mice (10–25 weeks old) were changed from normal rodent diet to a high
fat diet containing 23% fat from lard, supplemented with 0.15% (w/w) cholesterol (Special
Diets Services, UK). Three weeks after commencing the high-cholesterol diet, the animals
were anaesthetised with halothane and had six 0.5 cm3 pieces of sterile sponges (containing
Matrigel (BD Biosciences, UK)) placed dorsally, subcutaneously under aseptic conditions and
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buprenorphine analgesia. The high-fat diet continued for 4 weeks post-surgery, when the
sponges were recovered. For controls, age-matched male C57/129 mice were fed a normal
chow diet before and after sponge insertion as above. Water and food were given ad libitum.
Mice were euthanized by an overdose of halothane and the sponges removed using aseptic
technique.
FCMs were purified from sponges removed from fat-fed ApoE null mice based on their
lower buoyant density than other cells followed by differential adherence to plastic, whereas
NFM were purified by differential adherence alone [21,22]. Purified cells were used for RNA
extraction (Illumina array, RT-qPCR), viability (Trypan blue), lipid content (histochemistry)
or identification of cell type (RT-qPCR, immunocytochemistry). Some whole sponges from
ApoE-/- mice were fixed in 10% phosphate-buffered formalin and paraffin-embedded; 3 μm
sections were then cut and used for immunohistochemistry.
Development of atherosclerosis. ApoE-/- male mice commenced a high-fat diet at 5
weeks of age. Twelve weeks later the animals were killed and perfusion fixed at normal pressure
with phosphate-buffered saline (PBS) followed by 10% phosphate-buffered formalin. Brachio-
cephalic arteries were dissected out as described previously [24] and embedded in paraffin. Sec-
tions (3 μm thick) were prepared and used for immunohistochemistry.
Transcriptomic comparison of FCMs and NFMs
Total cellular RNA was extracted using the Qiagen RNease MiniKit (UK) according to the
manufacturer’s instructions. RNA concentration was determined using NanoDrop spectrome-
try (NanoDrop Technologies, USA). RNA samples of high quality (A260/280>2) (n = 4) were
compared using Illumina bead chips (MouseRef8 v2.0 Expression BeadChips, Illumina, USA)
at 1 μg/sample.
Functional Annotation. All genes from the dataset that met the unadjusted P-value cut-
off of 0.01 were uploaded to the Ingenuity Pathways Analysis (Ingenuity Systems, www.
ingenuity.com) system and included in the analysis. Each identifier was mapped to its corre-
sponding object in the Ingenuity Knowledge Base. Functional analysis identified the biological
functions and canonical pathway analysis identified the pathways that were most significant to
the data set. Network maps were also generated within Ingenuity Pathway Analysis. Differen-
tially expressed genes were overlaid onto a global molecular network developed from informa-
tion contained in the Ingenuity Knowledge Base and networks of these molecules
algorithmically generated based on their connectivity. Molecules are represented as nodes, and
the biological relationship between two nodes is represented as an edge (line). The intensity of
the node colour indicates the degree of up- (red) or down- (green) regulation. Nodes are dis-
played using various shapes that represent the functional class of the gene product. Edges are
displayed with various labels that describe the nature of the relationship between the nodes
(e.g., P for phosphorylation, T for transcription).
Differentially expressed genes were also submitted to GO annotation and clustering using
DAVID Bioinformatics Resources (National Institute of Allergy and Infectious Diseases
(NIAID) 2008, NIH, http://david.abcc.ncifcrf.gov).
RNA isolation and quantitative reverse transcriptase polymerase chain reaction (RT-
qPCR) assays. The array results were validated and expanded on RNA samples prepared in
the same way using RT-qPCR (n = 5–7) with selected primer pairs (Table 1). For reverse tran-
scription, 100 ng of total RNA was used to make cDNA, using a Qiagen Quantitect Reverse
Transcripase Kit according to the manufacturer’s instructions. Sequences of the PCR primer
pairs used to amplify the respective cDNAs were designed using Ensembl and Primer3, and the
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Table 1. Primer sequences used in this study.
GENE ALTERNATIVE NAME SPECIES PRIMER SEQUENCE
36B4 ribosomal protein, large, P0, RPLP0 human GCCCAGGGAAGACAGGGCGA
GCGCATCATGGTGTTCTTGCCCA
NR2B2 retinoid X receptor β, RXRβ mouse GGTGCTGACAGAGCTAGTGTCCAA
TGCTTGCAATAGGTCTCCAGTGAG
NR2B1 RXRα mouse AGGACAGTACGCAAAGACCTGACC
ATGTTTGCCTCCACGTATGTCTCA
NR1H3 liver X receptor α, LXRα mouse GCAGGACCAGCTCCAAGTAGAGAG
CACAAAGGACACGGTGAAACAGTC
NR1H2 LXRβ mouse GGCGGCCCAACTGCAGTGCAACAA
GCAAAGCGTTGCTGGCGGGCATCT
SREBF1 sterol regulatory element-binding transcription factor-1,
SREBP1
mouse AGGCCATCGACTACATCCG TCCATAGACACATCTGTGCCTC
FASN fatty acid synthase mouse GGCTCTATGGATTACCCAAGC CCAGTGTTCGTTCCTCGGA
MSR1 macrophage scavenger receptor-1, SR-A1, SCARA1 mouse GCTGCCCTCATTGCTCTCT CTGGAAGCGTTCCGTGTCT
CD36 thrombospondin receptor mouse GTACAGCCCAATGGAGCCA AACCCCACAAGAGTTCTTTCAAA
SCARB1 scavenger receptor B1, SR-B1 mouse GGTGCGCCTCTGTTTCTCTC
AGAACTACTGGCTCGATCTTCCCT
ABCA1 ATP-binding cassette, sub-family A1 mouse CTCAGTTAAGGCTGCTGCTG TCAGGCGTACAGAGATCAGG
PPARγ peroxisome proliferator-activated receptor-γ mouse TTGACAGGAAGGACAACGGACAAA
TGTGATCTCTTGCACGGCTTCTAC
COL1α1 collagen 1α1 mouse GATGATGCTAACGTGGTTCGTGAC
CCATGTTGCAGTAGACCTTGATGG
COL4α1 collagen 4α1 mouse CTGGCACAAAAGGGACGAG CGTGGCCGAGAATTTCACC
COL6α1 collagen 6α1 mouse ATGTGACCCAACTGGTCAACTCAA
AGCATGGAAGACAGAACACAGACG
COL8α1 collagen 8α1 mouse TCATCATTTCCCTGAACTCTGTC
CAAAGGCATGTGAGGGACTTG
BGN biglycan mouse TAGCCAGTCCCTCCACAAACAAAT
AGGAAGCTCCTTGATCCTCGTCTT
DCN decorin mouse CACAACCTTGCTAGACCTGC GAAGTTCCTGGAGAGTTCTGG
CTGF connective tissue growth factor human GGTGTACCGCAGCGGAGAGT GGGCCAAACGTGTCTTCCAG
BMP1 bone morphogenic protein v1,2 mouse AGACCTTTATTCCCATGCCCAGTT
TTCTTGGAGATGGTGTCGTCAGAG
THBS1 thrombospondin-1 mouse GGGCAAAGAACTTGTCCAGACTGT
ACTGGGTGACTTGTTTCCACATCA
TGFβ1 transforming growth factor-β1 mouse CTCCCGTGGCTTCTAGTGC GCCTTAGTTTGGACAGGATCTG
FOS FBJ murine osteosarcoma viral oncogene homolog mouse TTCGACCATGATGTTCTCG TTGGCACTAGAGACGGACAGA
FosB FosB mouse CCCTCCTGCATATCTTTGTCCTGT
CTGTCATTTCCTCGTTGGGTCTCT
JUN jun proto-oncogene mouse TGACTGCAAAGATGGAAACGA
CAGGTTCAAGGTCATGCTCTGT
JunB JunB mouse TCACGACGACTCTTACGCAG CCTTGAGACCCCGATAGGGA
SMAD2 Smad2 v1,2 mouse ATGTCGTCCATCTTGCCATTC AACCGTCCTGTTTTCTTTAGCTT
SMAD3 Smad3 mouse TGCACAGCCACCATGAATTAC TCCATCTTCACTCAGGTAGCC
ACVR1 activin A receptor-1/ALK2 v1,2,3 mouse AATGGTGAGCAATGGTATAGTG
GGGTCTGAGAACCATCTGTTAGG
TBFBR1 TGFβ receptor-1/ALK5 mouse CAGCTCCTCATCGTGTTGGTG GCACATACAAATGGCCTGTCTC
CTSC cathepsin C mouse GCAGGTCATCTACAATGCAACCAG
TGGAGCATAAATGCTTCTAAGGGA
CTSE cathepsin E mouse GCAGGTCATCTACAATGCAACCAG
TGGAGCATAAATGCTTCTAAGGGA
(Continued)
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Table 1. (Continued)
GENE ALTERNATIVE NAME SPECIES PRIMER SEQUENCE
CTSB cystatin b mouse AGGTGAAGTCCCAGCTTGAAT TCTGATAGGAAGACAGGGTCA
CSTF cystatin f mouse TGTTCCAAAGATTTGATCTCCAG
GTACCAGGGCTTTGCTGACAT
LYZ lysozyme v1&2 mouse GAATGCCTGTGGGATCAATTGC GCTGCAGTAGAAGCACACCG
MMP2 matrix metalloproteinase-2 mouse GGCTGACATCATGATCAACTTTGG
GCCATCAGCCGTTCCCATACTTTAC
MMP9 MMP9 mouse AGAGAGGAGTCTGGGGTCTGGTTT
GAGAACACCACCGAGCTATCCACT
MMP12 MMP12 mouse AATTACACTCCGGACATGAAGCGT
GGCTAGTGTACCACCTTTGCCATC
MMP13 MMP13 mouse ATGATGATGAAACCTGGACAAGCA
ATAGGGCTGGGTCACACTTCTCTG
MMP14 MMP14 mouse ACCACAAGGACTTTGCCTCTGAAG
CACCGAGCTGTGAGATTCCCTTGA
MMP23 MMP23 mouse CAAGGTTGGTGAGAGAGGGTAGGA
AGGAGTAGGTGCTGAGAACACGCT
TIMP1 tissue inhibitor of metalloproteinase-1 mouse AGGAACGAAATTTGCACATCAGT
CAAAGTGACGGCTCTGGTAGTCCT
TIMP2 TIMP2 mouse GACTCCCCCTCAGACTCTCCCTAC
CATATTGATACCACCGCACAGGAA
TIMP3 TIMP3 mouse CACATCAAGGTGCCATTCAGGTAG
GTTCTCTCCTCCTCAACCCAAACA
NOS2 nitric oxide synthase-2, iNOS mouse CTCATGACATCGACCAGAAGCGT
TATATTGCTGTGGCTCCCATGTTG
IL-6 interleukin-6 mouse GTTCTCTGGGAAATCGTGGA TTCTGCAAGTGCATCATCGT
CCL2 chemokine (C-C motif) ligand-2, MCP1 rabbit GCTTGCCCAGCCAGATGCCGTGAA
GGTTGGCAATGGCATCCTGGACCC
NF-κB1 nuclear factor of kappa light chain polypeptide gene
enhancer in B-cells 1
mouse GGAGGCATGTTCGGTAGTGG CCCTGCGTTGGATTTCGTG
ARG1 arginase-1 mouse AGTCTGGCAGTTGGAAGCATCTCT
TTCCTTCAGGAGAAAGGACACAGG
ARG2 arginase-2 mouse ACAGCCAGACTAGCACTGGATGTC
CGAATGCCTTGCAACTCTGTAATG
Chi3l3 chitinase-like 3, Ym1 mouse CAGGTCTGGCAATTCTTCTG GTCTTGCTCATGTGTGTAAGTG
CD206 mannose receptor, MRC1 mouse CCATTTATCATTCCCTCAGCAAGC
AAATGTCACTGGGGTTCCATCACT
RND3 member Rho GTPase family human GGGACACTTCGGGTTCTCCTTACT
TGGACAAAATTCCTGGATTTCACC
SARAF store-operated calcium entry-associated regulatory factor,
Tmem66
mouse GGCTTTAAGTCGGAGTTCACAGGA
TCGAGTCTGCATTAGAGGATGCAC
CMPK2 cytidine monophosphate (UMP-CMP) kinase 2 mouse GTTTCCTCGGTGTAGGAGCTGTGT
CTCGAAGCTGACTTCACATGCAAT
MYH11 smooth muscle myosin heavy chain v1&2 mouse ATGAGGTGGTCGTGGAGTTG GCCTGAGAAGTATCGCTCCC
MAPK14 mitogen-activated protein kinase 14 mouse ATAAGAGGATCACAGCAGCCCAAG
GACAGAACAGAAACCAGGTGCTCA
PICALM picalm mouse CCATTCCAAGCTTAAACCCTTTCC
AGGCCACTGTTGGTTTGAGAAGTC
GZMA granzyme a mouse TGCTGCCCACTGTAACGTG GGTAGGTGAAGGATAGCCACAT
GZMB granzyme b mouse TGCTGCTAAAGCTGAAGAGTAAG
CGTGTTTGAGTATTTGCCCAT
NPC1 Niemann Pick type 1 mouse GCTGTGAGCTGTGGTCTGC CTCACTCGGCTTCCTTTGGTA
NPC2 Niemann Pick type 2 mouse AGGACTGCGGCTCTAAGGT AGGCTCAGGAATAGGGAAGGG
(Continued)
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specificity of the sequence confirmed using Nucleotide blast (NCBI). Samples were compared,
either after normalising to a housekeeping gene (36B4) or as copies per ng RNA.
Immunocytochemistry and (immuno)histochemistry
After isolation, FCMs and NFMs were adhered to coverslips to allow identification of cell type
(general leukocyte (Giemsa staining), macrophage or SMC/fibroblast; antibodies as listed in
Table 2) after use of a mouse-on-mouse immunodetection kit (BMK-2212, Vector, USA) as
necessary. Lipid content was identified after staining with Oil-Red-O (Sigma) and nuclei were
counterstained with haematoxylin. Paraffin embedded sections of formalin-fixed sponges or
brachiocephalic arteries from ApoE null mice were examined for expression of the various pro-
teins (antibodies listed in Table 2), as were coverslips from RAW or bone marrow-derived
monocyte (BMDM) cultures (S1 File). Specimens were visualised using light or fluorescent
microscopy after labelling primary antibodies or controls with the appropriate secondary anti-
bodies and substrate/fluorophore systems (DAB (Sigma), streptavidin-594 (Molecular Probes,
Life Technologies). Nuclei were stained with haematoxylin (light microscopy) or DAPI (fluo-
rescent; Prolong-Gold anti-fade medium + DAPI, Invitrogen). Irrelevant antibodies or appro-
priate sera were used in negative controls.
Statistics
Statistical analysis of the microarrays was performed using the 'R' Bioconductor Lumi and
Limma packages, applying the linear models and empirical Bayes methods included in the
package [25]. Variance stabilizing transformation was performed using the Robust Spline Nor-
malization (RSN) algorithm [26] with unsupervised analysis methods such as Principal Com-
ponent Analysis and Hierarchical Clustering used for initial data exploration. Statistical
analysis of differential expression consisted of a univariate model to detect individual genes
that are significantly different in abundance between the conditions [25]. P-values were
adjusted for multiple comparisons, using the False Discovery Rate (FDR) Benjamini-Hochberg
method. Differential expression was classified as significant (P<0.01 after FDR correction for
multiple testing) or suggestive (P<0.01 unadjusted). The significance of the association
between the data set and the canonical pathway was measured by either a ratio of the number
of molecules from the data set that map to the pathway divided by the total number of mole-
cules that map to the canonical pathway is displayed, or by using a right-tailed Fisher’s exact
test, to calculate a P-value determining the probability that the association between the genes
in the dataset and the canonical pathway is explained by chance alone.
For the RT-qPCR, data differences between the two groups were tested for significance with
Student’s t-test, using a logarithmic transformation or the Mann-Whitney U-test if the data
were not normally distributed, using GraphPad Instat (USA). P-values of less than 0.05 were
considered statistically significant. Values are expressed as mean ± standard deviation.
Table 1. (Continued)
GENE ALTERNATIVE NAME SPECIES PRIMER SEQUENCE
CCR7 C-C chemokine receptor type-7 mouse TGTACGAGTCGGTGTGCTTC
GGTAGGTATCCGTCATGGTCTTG
VDR vitamin D receptor mouse ACCCTGGTGACTTTGACCG GGCAATCTCCATTGAAGGGG
CD44 CD44 mouse GTCTTCTTCCGGCTCTCCATGTAA
ATCTCACATCCAATGGGACAAGGT
doi:10.1371/journal.pone.0128163.t001
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Results
Yield and purity of cells isolated from subcutaneous granulomas
The yield of cells purified by floatation and adhesion from sponges implanted for 4 weeks into
fat-fed ApoE null mice was 4.6 ± 2.7 x 106. This was comparable to the 6.3 ± 2.4 x 106 cells iso-
lated by adhesion only from control non-fat-fed wild-type mice after 4 weeks, which is similar
to values previously reported after 7 days [27]. Cells from the ApoE null and control mice were
96 ± 5.8% or 87 ± 10%MOMA2 positive, respectively, and only 0.86 ± 1.2% or 1.4 ± 1.8% α/γ-
SM actin positive, respectively. Data from RT-qPCR confirmed that the cell preparations con-
tained low levels of SM myosin heavy chain (SM1/SM2) (averaging less than 2.5 copies/ng
RNA), implying they have little SMC contamination. Whereas almost all of the cells in the
preparations from the ApoE null mice had lipid-rich (Oil-Red-O positive) inclusions, there
were none in cell preparations from control mice (Fig 1). Hence cells isolated from the fat-fed
ApoE null mice were indeed foam cell macrophages (FCMs), whereas those from the control
mice were non-foamy macrophages (NFMs).
Table 2. Primary and secondary antibodies used in this study.
Antibody Clone/Cat # Type Supplier
Primary antibodies/controls
mouse monocyte/macrophage MOMA2 /MBS530837 Rt_Mab Biosource International, USA
Human α/γ-SM actin HHF35 /M0635 Mm_Mab Dako, UK
human smooth muscle myosin heavy chain (SM-1, SM-2) hSM-V /M7786 Mm_Mab Sigma, USA
human biglycan - /ab58562 Gt_Pab Abcam, USA
mouse CTGF - /ab6992 Rb_Pab Abcam
human LXRα (NR1H3) - /LS-B3526 Rb_Pab Lifespan Biosciences, USA
human cFOS - /ab7963 Rb_Pab Abcam
human phospho-SMAD2 (ser465/467) 138D4 /3108 Rb_Mab Cell Signalling Technology (New England Biolabs, UK)
human total SMAD2 D43B4 /5339 Rb_Mab Cell Signalling Technology
human phospho-SMAD3 (ser423/425) C25A9 /9520 Rb_Mab Cell Signalling Technology
human total SMAD3 C67H9 /9523 Rb_Mab Cell Signalling Technology
rabbit GAPDH 6C5 /MAB374 Mm_Mab Chemicon (Millipore)
normal rabbit IgG control - /X0936 Dako
- I5006 Sigma
normal rat IgG control - /6-001-A R&D Systems
normal mouse IgG1 control - /X0931 Dako
normal mouse IgG2b control - /X0944 Dako
goat serum - /X0907 Dako
Secondary antibodies
Mouse Ig - /P0260 Rb_Pab Dako
- /B7264 Gt_Pab Sigma
Rat Ig - /E0468 Rb_Pab Dako
- /80-9520 Mm_Pab Zymed (Invitrogen)
Rabbit Ig - /P0448 Gt_Pab Dako
- /A0545 Gt_Pab Sigma
- /7074 Gt_Pab Cell Signalling Technology
Goat Ig - /E0466 Rb_Pab Dako
- /P0449 Rb_Pab Dako
doi:10.1371/journal.pone.0128163.t002
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Genes and pathways indicated from the array
RNA from FCMs and NFMs (n = 4) was subjected to microarray analysis on the Illumina plat-
form (GEO accession number GSE70126). Using an adjusted P-value of<0.01, we found only
29 differentially expressed genes. However, using a less stringent unadjusted P-value<0.01, a
total of 749 genes appeared to be differentially expressed, with 369 up-regulated and 380
down-regulated. A detailed list can be found in S1 Table. Canonical signalling analysis revealed
that the most enriched pathway in FCMs compared to NFMs was that related to LXR and its
obligate partner, retinoid acid receptor (RXR) (Fig 2), confirming the results of a previous
study comparing peritoneal FCMs and NFMs from LDL receptor null mice [23]. The second
most over-enriched pathway was that previously associated with hepatic fibrosis (Fig 2). Inter-
estingly, functions found to be enriched and/or up-regulated in FCM by Ingenuity Functional
Pathway analysis (Table 3) also implicated connective tissue development as well as cell regula-
tion, differentiation and proliferation.
The 2 most statistically significant networks generated from the array data (Fig 3) pointed
to a regulatory node around platelet derived growth factor (PDGF) and transforming growth
factor-β (TGFβ), which have been previously implicated in tissue fibrosis [28]. Network analy-
sis also suggested that FOS and FosB, which are components of the activator protein-1 (AP-1)
transcription factor complex that is known to be downstream of PDGF and TGFβ activation
[29], might be major contributors to the differences between FCMs and NFMs (Fig 3). The net-
work analysis focused our attention on extracellular matrix protein and pro-fibrotic genes,
including several collagen polypeptides, decorin, biglycan and bone morphogenic protein 1
(BMP1, a pro-collagen convertase), that were strongly over expressed in FCMs relative to
NFMs. We also further investigated expression of connective tissue growth factor (CTGF),
which is a major contributor to fibrosis; and proteases, including cathepsins and matrix metal-
loproteinases (MMPs), which have been implicated in plaque rupture [30].
Comparison of array and RT-qPCRmeasurements of differentially
expressed mRNAs
Despite the low stringency and hence potentially high false discovery rate of our initial analysis,
most of the genes found to be differentially expressed in the array (Fig 4A) were validated by
Fig 1. Lipid droplets were found only in macrophages frommice fed a high-fat diet.Oil-Red-O staining for lipid (orange-red) in A) FCMs and B) NFMs
isolated from sponges. Nuclei appear purple (haematoxylin). Magnification x 400.
doi:10.1371/journal.pone.0128163.g001
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Fig 2. Canonical pathway analysis. The canonical pathways most enriched in FCMs were anti-
inflammatory (LXR) and pro-fibrotic (derived from array data). Blue bars indicate significance, orange line
indicates ratio. (Ingenuity Systems Inc).
doi:10.1371/journal.pone.0128163.g002
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RT-qPCR, often with increased ratios (Fig 4B and Table 4). In addition, several candidate
genes related to the identified pathways were found to be differentially expressed by RT-qPCR
on greater numbers of preparations (Fig 4B and Table 4).
LXR-related genes. Genes associated with the LXR pathway that was identified by canoni-
cal signalling analysis were of special interest, given the previous data comparing peritoneal
FCMs and NFMs from LDL receptor null mice [23]. RXRβ was increased 1.2-fold in the array
(P = 0.0019, Fig 4A) and this was confirmed by RT-qPCR (2-fold, P = 0.0303) with over 1000
copies/ng RNA in FCMs (Fig 4B and Table 4). RXRα was also over expressed in FCMs
(P = 0.0170) but these cells only had 160 copies/ng RNA. LXRα and LXRβ were over expressed
in FCM (P = 0.0177 and P = 0.0478, respectively), although both had less than 25 copies/ng
RNA. Looking at downstream genes, sterol regulatory element binding protein 1 (Srebp1) was
increased in FCMs (P = 0.0303) and had over 1000 copies/ng RNA, whereas fatty acid synthase
(FASN), also increased in FCMs (P = 0.0182), had less than 60 copies/ng RNA. Scavenger
receptor class F member 2 (SCARF2) was 2-fold elevated in FCMs in the array (P = 0.0081)
and macrophage scavenger receptor 1 (MSR1, scavenger receptor A1 (SR-A1)) was increased
17.5-fold in FCMs by RT-qPCR (P = 0.0038). The mRNAs for scavenger receptors CD36 and
scavenger receptor class B, member 1 (SCARB1, SR-B1) (both associated with TGFβ [28,31–
34]), although abundant in FCMs, were not significantly different from those in NFMs. There
were no significant differences between FCMs and NFMs in ATP binding cassette transporter
isoform A1 (ABCA1) or peroxisome proliferator-activated receptor-γ (PPARγ expression,
although both FCMs and NFMs had very high expression levels of these genes (130000–
250000 copies/ng RNA), as previously reported [10].
Extracellular matrix structural proteins. Probably the most unexpected finding from our
experiments was that several collagen polypeptide genes, as well as core proteins of the proteo-
glycans, biglycan and decorin, and the matricellular protein CTGF, were 2 to 6.5-fold up-regu-
lated in FCM compared with NFM in the array (Fig 4A). All of these genes are known targets
for induction by PDGF and/or TGFβ [29,35]. The large increases in mRNAs for collagens 1, 4
and 6 were confirmed by RT-qPCR (11–20 fold increase in FCM, Fig 4B and Table 4). Col-
lagen1α1 was the most abundant, with 18000 copies/ng RNA in FCMs and 1000 in NFMs
(P = 0.0016, Table 4). FCMs had more than 63-fold more mRNA for CTGF than did NFM
(P = 0.0001), also confirming the array result. The mRNAs for biglycan and decorin core pro-
teins were also significantly increased and highly abundant, with 23000 or 100000 copies in
FCM and only 2900 or 1200 in NFM, respectively (biglycan P = 0.0185, decorin P = 0.0482).
The expression of BMP1, which is known to be up-regulated by TFGβ and potentially involved
in the regulation of TGFβ activation [36], was considerably increased in FCM, with 540000
and 48000 copies/ng RNA in FCMs and NFMs, respectively (P = 0.0081; Fig 4B and Table 4).
By contrast, thrombospondin 1 (THBS1), which is known to bind and activate TGFβ [36] was
Table 3. Functions enriched/regulated in FCMs by Ingenuity Functional Pathway analysis.
Rank Functions enriched/regulated in FCMs Score
1 Dermatological diseases and conditions, Connective tissue development and function,
Tissue morphology
52
2 Cancer, Cellular growth and proliferation, Nervous system development and function 30
3 Cardiovascular disease, Cellular growth and proliferation, Haematological system
development and function
28
4 Cancer, Cellular movement, Cell death 23
5 Cell signalling, Molecular transport, Vitamin and mineral metabolism 23
6 Cellular growth and proliferation, Cancer, Cell death 13
doi:10.1371/journal.pone.0128163.t003
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significantly reduced in FCM (P = 0.0051; Fig 4B), although both FCMs and NFMs had abun-
dant THBS1 mRNA (23000 and 81000 copies/ng, respectively, Table 4).
Fibrosis-related signalling and associated molecules. Levels of TGFβ1 mRNA were simi-
lar in FCMs and NFMs (Fig 4B). However, the PDGF and TGFβ related activator protein-1
(AP-1) family members FOS and FosB were over expressed over 5-fold, whereas JUN and JunB
were 1.5 and 2.4 fold higher, respectively, in FCMs compared to NFMs in the array (Fig 4A).
Fig 3. Network maps of genes differentially regulated in FCM and NFM array (top 2 networks).
Molecules are represented as nodes, and the biological relationship between two nodes is represented as an
edge (line). Continuous lines represent direct interactions, while indirect ones are represented by interrupted
lines. The intensity of the node colour indicates the degree of up- (red) or down- (green) regulation. Colour of
node indicates the presence (grey) or absence (white) of a given gene in the study. No change in M1/M2
markers were observed, but there was a regulatory node around PDGF and TGFβ (which were absent from
the array) (Ingenuity Systems Inc).
doi:10.1371/journal.pone.0128163.g003
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Data from RT-qPCR (Fig 4B) confirmed that FCMs expressed more FOS, JUN and JunB than
NFMs, with several thousand copies of each per ng RNA (Table 4). The level of FosB expres-
sion was lower than the other signalling molecules, but still over-expressed in FCMs compared
with NFMs, with 130 copies/ng RNA in FCM and only 16 copies/ng RNA in NFM (P = 0.0001;
Fig 4B). By contrast with the increases in AP-1 factors, signalling factors SMAD 2 and 3 that
Fig 4. Genes differentially regulated in FCM and NFM. A) array; B) RT-qPCR). Cyan = LXR-related genes,
red = extracellular matrix structural proteins, yellow = fibrosis-related signalling and associated molecules,
purple/blue = degradative enzymes/inhibitors, green = genes associated with M1 and M2 polarisation,
peach = miscellaneous genes. Genes not present on the Illumina chip or not qPCR verified are left blank.
*P<0.05.
doi:10.1371/journal.pone.0128163.g004
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Table 4. Levels of mRNAs by RT-qPCR in FCMs and NFMs (n = 5–7).
Gene FCM/NFM FCMs (copies/ng RNA) FCM SD NFMs (copies/ng RNA) NFM SD P-value
36B4 1.39 3564 683.1 2558 228.0 0.3434
RXRβ 1.98 5903 3100 2982 1173 0.0303
RXRα 2.08 167.1 59.10 80.25 32.69 0.0170
LXRα 4.10 23.37 18.822 5.703 2.298 0.0177
LXRβ 2.69 2.000 1.219 0.743 0.108 0.0478
Srebp1 2.13 1332 712.8 624.3 174.7 0.0303
FASN 6.90 57.23 60.56 8.297 4.795 0.0182
MSR1 17.5 37074 45725 2116 1002 0.0038
CD36 2.47 1912 1890 774.8 880.3 0.4318
SCARB1 2.92 150.7 117.6 51.51 25.46 0.1061
ABCA1 1.48 44043 27951 29749 14210 0.3222
PPARγ 1.83 248580 95420 136141 30771 >0.9999
Col1α1 17.8 18252 14723 1024 708.9 0.0016
Col4α1 11.1 347.1 304.9 31.39 18.82 0.0041
Col6α1 19.7 1045 1194 52.95 41.89 0.0078
Col8α1 84.4 3.529 4.392 0.0418 0.0494 0.0380
BGN 9.08 22551 21086 2484 1678 0.0185
DCN 8.30 9964 9985 1201 795 0.0482
hCTGF 63.5 3.951 2.933 0.0623 0.0637 0.0001
BMP1 11.4 544680 473325 47913 20134 0.0081
THBS1 0.29 23317 7268 81297 37646 0.0051
TGFβ1 1.19 37.65 20.84 31.52 14.56 0.5855
FOS 13.7 29675 21365 2171 1416 0.0038
FosB 8.02 128.4 77.37 16.00 5.779 0.0001
JUN 3.09 24095 11387 7793 7144 0.0185
JunB 1.95 186454 63475 95703 51901 0.0255
SMAD2 0.87 946 585 1091 350 0.6325
SMAD3 0.82 132.5 100.0 161.1 105.1 0.6421
ACVR1 1.21 84.40 52.27 69.62 25.40 0.5750
TGFBR1 0.70 972 382 1392 1174 0.3101
CTSC 6.60 4003 2215 606.5 246.2 0.0033
CTSE 13.4 22.72 10.60 1.6993 1.1338 <0.0001
CSTB 0.72 27327 11840 38125 14139 0.1805
CSTF 0.82 235.1 127.5 285.1 136.3 0.5296
LYZ 8.84 105455 82637 11936 14926 0.0177
MMP2 9.82 654.4 500.6 66.62 39.62 0.0103
MMP9 0.94 799.2 562.8 854.6 823.8 0.8920
MMP12 1.07 13415 8590 12553 9439 0.8804
MMP13 0.20 2330 1452 11368 4487 0.0007
MMP14 0.75 35000 12138 46875 25061 0.4901
MMP23 6.98 5109 3772 732.0 388.9 0.0080
TIMP1 0.67 2037 1393 3023 1707 0.2955
TIMP2 3.23 692.0 637.5 214.5 148.5 0.2677
TIMP3 3.81 19.70 18.27 5.165 5.289 0.2677
NOS2 1.27 13143 8979 10331 5791 0.5550
IL6 0.33 443.6 467.4 1333 1419 0.2126
CCL2 2.15 3.290 2.290 1.530 0.850 0.1061
(Continued)
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are activated by TGF family members by phosphorylation appeared to be down-regulated in
FCMs in the array, as were the TGFβ receptors activin A receptor type 1 (ACVR1, ALK2) and
TGFβ Receptor 1 (TGFBR1, ALK5) (Fig 4A). However, none of these small fold changes could
be confirmed by RT-qPCR (Fig 4B).
Degradative enzymes. The most differentially expressed gene in the array was cathepsin C
(CTSC), with a 20-fold change between the FCM and the NFM (P = 0.0000, Fig 4A). This dif-
ference was confirmed by RT-qPCR (Fig 4B) with 4000 and 600 copies in FCMs and NFMs,
respectively (Table 4). Cathepsin E (CTSE) was also over expressed in FCMs (Fig 4A and 4B),
although there were few copies of mRNA in either type of macrophage. In contrast, cystatins E
and F were either not changed or slightly decreased in FCMs (Fig 4A and 4B and Table 4).
Lysozyme (LYZ) was over-expressed (4-fold) in FCMs in the array (Fig 4A) and RT-qPCR (Fig
4B), where FCMs and NFMs contained 105000 and 12000 lysozyme copies/ng RNA, respec-
tively (P = 0.0177, Table 4). Turning to the MMPs, we found that the gelatinase, MMP2, and
the cysteine-rich MMP, MMP23, were over expressed in FCMs (650 or 5100 copies in FCM
and only 67 or 730 in NFM, respectively). In contrast, for those MMPs that are related to M1
activation [24], there was no change in MMP9 (Table 4) and the abundant M1-related collage-
nase, MMP13, was down-regulated in FCMs (2.9-fold, P = 0.0302 in the array and 4.9 fold
P = 0.0007 by RT-qPCR). The tissue inhibitor of MMPs, TIMP-2, appeared to be increased in
FCMs compared with NFMs in the array, although this could not be confirmed using RT-
qPCR (Fig 4A and 4B and Table 4).
Genes associated with M1 and M2 polarization. From the array, there were no differ-
ences in genes associated with M1 macrophage activation, such as inducible nitric oxide
synthase (NOS2), IL-6, MMP9 or chemokine (C-C motif) ligand 2 (CCL2, MCP1). However,
as mentioned above, MMP13 was decreased, and in the NF-κB pathway, which is implicated in
M1 activation [37,38], NF-κB1 was also down-regulated in FCMs in the array (Fig 4A). Data
from RT-qPCR (Fig 4B), confirmed that NOS2 expression was high in both FCM and NFM,
13000 and 10000 copies/ng RNA, respectively (P = 0.5550). CCL2 levels were also not signifi-
cantly different in FCMs and NFMs (P = 0.1061), nor was MMP9 (Table 4). NF-κB1 was lower
in FCM than in NFM, with 980 and 2400 copies/ng RNA in FCMs and NFMs, respectively
(P = 0.0219, Fig 4B and Table 4), confirming the array data. There were no differences in M2
marker genes, Arg1, Ym1 and the mannose receptor (CD206) in the array (Fig 4A). By RT-
qPCR, Arg1 expression in both FCMs and NFMs was high, with 72450 and 42300 copies/ng
RNA, respectively (P = 0.3862). Although Arg2 levels (suggesting either M1 or M2c activation)
were lower in the FCM, the differences did not reach significance (FCM 6900, NFM 11000 cop-
ies/ng RNA, respectively, P = 0.2270). Both FCMs and NFMs expressed the M2 markers Ym1
(1000–2000 copies/ng RNA) and CD206 (15000–35000 copies/ng RNA) at similar levels.
Table 4. (Continued)
Gene FCM/NFM FCMs (copies/ng RNA) FCM SD NFMs (copies/ng RNA) NFM SD P-value
NF-κB1 0.41 978.9 405.6 2378 1248 0.0219
ARG1 1.71 72449 55730 42307 45624 0.3862
ARG2 0.63 6887 4015 10866 6745 0.2270
YM1 0.63 1198 610.1 1905 891 0.1315
CD206 2.22 34553 14498 15565 5164 0.5934
RND3 8.43 104.32 54.87 12.38 6.575 0.0004
SARAF 2.88 996.1 710.6 345.3 147.0 0.0194
Cmpk2 0.25 1265 895 5010 2654 0.0129
doi:10.1371/journal.pone.0128163.t004
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Together these results indicate that FCMs and NFMs display similar levels of established mark-
ers for either M1 or M2 polarization.
Miscellaneous genes. Other genes that were confirmed as differentially regulated in the
two set of macrophages were Rho family GTPase 3 (RND3), which regulates the organisation
of the actin cytoskeleton in macrophages and other cells [39] and store-operated calcium
entry-associated regulatory factor (SARAF, formerly Tmem66); both were elevated in FCMs
(P = 0.0004 and P = 0.0194, respectively). Cytidine monophosphate (UMP-CMP) kinase 2
(Cmpk2), which is involved in the terminal differentiation of monocytic cells [40], was lower
in FCMs (P = 0.0129, Fig 4B). Further details of the differences in the differentially expressed
genes that were validated using RT-qPCR can be found in Table 4.
Immunohistochemical validation of selected findings from the array
Given that the two pathways most increased at the mRNA levels in FCMs compared to NFMs
were the LXR and hepatic fibrosis pathways (Fig 2), we used immunohistochemistry to validate
these findings in sections of subcutaneous sponges from ApoE null mice. We also took the
opportunity, where possible, to compare plaque FCMs and adventitial NFMs in the same ath-
erosclerotic plaques from the brachiocephalic artery of ApoE null mice.
LXRα. LXRα protein was identified in 52 ± 26% of cells (n = 5) in sections of sponges
from ApoE null mice (Fig 5A) and in 53 ± 23% of the cells in plaques from brachiocephalic
arteries from ApoE null mice (Fig 5B, 5B’ and 5C,). Cells with nuclear (pink) and cytoplasmic
(red) staining were found throughout the plaque. Cells containing LXRα in their cytoplasm
were most often found near the lumen, while those cells closest to the internal elastic lamina,
deep within the plaque, tended to have less cytoplasmic LXRα (Fig 5B). Little cytoplasmic (and
even less nuclear) staining was found in adventitial cells (Fig 5C), and no staining at all in IgG
control sections (Fig 5D and 5E).
CTGF. Most FCMs but very few NFMs isolated from sponges stained for CTGF (Fig 6A
and 6B; red staining), which supports the mRNA data. Of cells in sponge sections from fat-fed
ApoE null mice, 49 ± 22% (n = 10) stained for CTGF (arrows in Fig 6C). FCMs in brachioce-
phalic artery plaque sections also had strong staining for CTGF (Fig 6D). SMC in the media
also stained for CTGF, as did the extracellular matrix of the adventitia, which obscured any
staining by adventitial cells. Approximately 90–95% (n = 6–7) of cells in the plaque, media and
adventitia stained for CTGF protein, intracellularly or in the surrounding matrix. This data
therefore confirmed the over expression of CTGF in sponge and plaque FCMs, and suggested
that there might be reduced staining from NFMs, at least in in the sponges.
cFOS. FCMs isolated from sponges had prominent cFOS immunostaining in their cyto-
plasm (red), with a third of cells also expressing cFOS in their nucleus (pink) (Fig 7A). Staining
was less pronounced in isolated NFMs (Fig 7B), and was only observed in a few nuclei. Staining
for cFOS was also observed of FCMs in subcutaneous sponge granulomas (Fig 7C), with
42 ± 22% of cells (n = 5) having nuclear cFOS staining (pink), and many having cFOS staining
(red) in their cytoplasm. 43–44% of cells within the BCA plaques (n = 2) also expressed nuclear
(pink) cFOS, with many also having cytoplasmic cFOS staining (Fig 7D and 7D’). A similar
proportion, 45–55%, of adventitial cells (from their shape possibly fibroblasts) also had nuclear
cFOS staining (Fig 7D and 7E). Overall, almost half of all cells in the plaque, adventitia or
sponge sections had nuclear cFOS staining. Clearly, at least some plaque FCMs were cFOS pos-
itive, which confirms the array and RT-qPCR findings.
Role of TGFβ1 and activation of SMAD2 signalling in FCMs. Members of the TGF
family signal through phosphorylation and nuclear translocation of SMADs, especially
SMAD2. Hence we hypothesised that FCMs in sponges and plaques might contain increased
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levels of nuclear pSMAD2 detectable by immunohisto/cytochemistry. As a positive control,
we first showed that TFGβ1 quickly stimulated SMAD2 and SMAD3 phosphorylation and
translocation to the nucleus by 45 minutes in mouse RAW cells (Fig 8A and 8B and Table B in
S1 File). Staining for nuclear pSMAD2 (pink) was found in 50 ± 12% of isolated FCMs; many
also had cytoplasmic staining (red). By contrast, nuclear pSMAD2 staining was detected in
only 10 ± 10% of NFM (n = 3, P = 0.0110, Fig 8C and 8D). Furthermore, 74–76% of the FCMs
in brachiocephalic artery plaques had pSMAD2 present in their nuclei (pink), with many also
Fig 5. LXRα in sponges and arteries from fat-fed ApoE null mice. LXRα is present in the cytoplasm (red)
and/or nucleus (pink, arrows) of A) FCMs in sections from a subcutaneous sponge, or; B) cells in the plaque
of a brachiocephalic artery. B’ higher magnification of plaque in B. C) LXRα is occasionally present in the
cytoplasm of the adventitial cells that are close to the media; D) sponge section negative control (only the
sponge spicule is red); E) negative control in a section from the same plaque as B. Blue = nuclei (DAPI),
green = autofluorescence. Magnification x 400 A-E, x 1000 B’.
doi:10.1371/journal.pone.0128163.g005
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having pSMAD2 in their cytoplasm (orange) (Fig 8E and 8E’). No staining was observed in an
IgG control section from the same plaque or in IgG control RAW cells (Fig 8F and 8G). This
provides strong evidence for SMAD2 signalling in FCMs in sponges and plaques.
Discussion
Main findings
Our experiments document novel differences between the transcriptomes of FCMs and NFMs
obtained from subcutaneous sponge-induced granulomas in living ApoE null mice. The most
significant changes were in the LXR/RXR pathway, which concurs with a study of peritoneal
FCMs and NFMs in LDL receptor null mice [23]. We also observed significant increases in
Fig 6. CTGF in sponges and arteries frommice.CTGF (red) is present in A) in FCMs, but not B) NFMs
isolated from sponges. Blue = nuclei (DAPI). CTGF (brown) is present in C) FCMs in sponge sections or; D)
throughout the plaque, media and adventitia of a brachiocephalic artery from a fat-fed ApoE null mouse. E)
sponge section negative control; F) negative control in a section from a brachiocephalic artery plaque.
Magnification x 200 (C, E), x 400 (A, B, D, F).
doi:10.1371/journal.pone.0128163.g006
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fibrosis-related gene expression in FCMs, including several collagen polypeptides and proteo-
glycan core proteins. Furthermore, we observed elevated levels of FOS and JUN transcription
factors that are associated with pro-fibrotic actions [41] and phosphorylation of the SMAD2
transcription factor that mediates actions of TGF family members [42]. FCMs from subcutane-
ous sponges from ApoE null mice were polarized neither towards the M1 (classically activated)
Fig 7. cFOS in sponge and artery macrophages frommice. cFOS is present in the cytoplasm (red) or
nucleus (pink, arrows) in isolated macrophages from A) mice fed a high-fat diet (FCMs) or B) a normal diet
(NFMs). cFOS was also observed in the cytoplasm (red, orange, yellow) and/or nucleus (pink, arrows) of cells
in sections from C) a subcutaneous sponge granuloma or D, E) a brachiocephalic artery from a fat-fed ApoE
null mouse. D’) higher magnification of plaque in D. Blue = nuclei (DAPI), green = autofluorescence.
Magnification x 400 A-E, x 1000 D’. See Fig 5C and 5D for negative control staining.
doi:10.1371/journal.pone.0128163.g007
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Fig 8. Phosphorylated SMAD proteins in RAW 264.7 cells and sponge or artery macrophages from
mice.RAW cells were exposed to 10 ng/ml TGFβ1 for 45 minutes. A) phospho-SMAD2 and B) phospho-
SMAD3 were present in the cytoplasm and nucleus of many cells. pSMAD2 was also found in C) the
cytoplasm and nucleus (arrows) from isolated FCMs, but only in the D) cytoplasm of NFMs. E) pSMAD is
present in the cytoplasm and nuclei (arrows) of plaques in a brachiocephalic artery a fat-fed ApoE null mouse.
E’) higher magnification of plaque in E. F) negative control in a section from the same plaque. G) RAW
negative control staining (rabbit IgG). Red/orange = cytoplasmic staining, pink = nuclear staining,
blue = nuclei (DAPI), green = autofluorescence. A, B, E’, G magnification x 1000, C, D, E, F magnification x
400.
doi:10.1371/journal.pone.0128163.g008
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nor M2 (alternatively activated) phenotypes. Our results demonstrate that FCMs formed in
vivo adopt a pro-fibrotic phenotype.
LXR/RXR pathway
LXRs act by heterodimer formation with RXRs and subsequent binding of the complex with
LXR response elements in target genes. They can also inhibit expression of other genes by antag-
onising the activity of transcription factors or by preventing the release of co-repressor com-
plexes from target-gene promoters [43]. We found that FCMs had increased expression of
LXRα and LXRβ, as well of their binding partners RXRα and RXRβ, as well as several down-
streammediators (e.g. Srepb1, FASN). Similar observations were reported previously in perito-
neal macrophages isolated from fat-fed LDL receptor null mice [23]; and loading of mouse
BMDMwith acetylated low density lipoprotein (LDL) in vitro also upregulates several LXR-
related genes [44]. On the other hand, loading with oxidised- (ox-) LDL for 24 hours down-reg-
ulates MSR1, FASN and SCARB1 but upregulates CD36 and ABCA1, most likely by modulating
transcription by ATF3 [45]. Such disparities dependent on both the type of lipids used and the
phenotypic state of the mouse macrophages before loading have been previously reviewed [46].
The pro-fibrotic response of FCMs
In addition to lipid-related genes, we found that the mRNAs of many extracellular matrix pro-
teins were up-regulated in FCMs. These included mRNAs for collagens 1, 4, 5, 6, 8, 16 and 18
as well as the pro-collagen convertase, BMP-1. Furthermore, mRNAs for the core proteins of
biglycan, decorin and versican, which are proteoglycans that bind to collagen and promote
matrix assembly and maturation, were elevated in FCMs (Table 4 and S1 Table). All of these
matrix proteins are present at high levels within plaques [47–49] but have been thought of as
products of SMCs or fibroblasts [35]. Our new data suggests that FCMs contribute to their
own surrounding extracellular matrix. Interestingly, FCMs recovered from the peritoneum of
LDL receptor null mice also overexpress collagen 1α2, collagen 3α1, collagen 6α1 and decorin
by 2–4 fold compared to NFMs (Supplementary Table IC of [23]). Hence the pro-fibrotic
transformation we observed in cells from subcutaneous granulomas in ApoE mice is replicated
in the LDL receptor null background and at another site. On the other hand, several transcrip-
tomic studies of mouse BMDM loaded with lipids for short periods in vitro did not note any
changes in fibrosis-related genes [44,45,50], which suggests that such changes may evolve
slowly or depend on the local microenvironment in vivo.
Collagens 1 and 3 are believed to be important in stabilizing plaques against rupture [51]. In
contrast, collagen 8 coincides with active remodelling, migration and increased production of
some MMPs [52,53]. Biglycan and versican are known to trap lipid within the matrix and
hence perpetuate lesion progression leading ultimately to instability [48,49,54]. The impact of
fibrotic transformation of FCMs could therefore be beneficial for stability through collagen
synthesis but promote plaque progression through proteoglycans.
Canonical pathway analysis and network maps suggested PDGF and TGFβ as a regulatory
node in the gene expression changes in FCMs compared to NFMs (Fig 3). At first sight this
seems counter-intuitive, because TGFβ has been shown to reduce foam cell formation in vitro
by decreasing scavenger receptor mRNA expression and oxidised LDL uptake [4]. However,
much previous literature establishes that TGFβ can stimulate collagen synthesis in the plaques
[29,35], as well as during the development of restenosis [55]. Proteolytic activation of latent
TGFβ, rather than increased expression, is often responsible for increased TGFβ activity [29].
Consistent with this, we found that TGFβ1 mRNA was not increased in FCMs compared with
NFMs; nor was the TGFβ1 receptor, ALK5. However, MMP2 was increased; and BMP1, which
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can also activate TGFβ, was up-regulated 11-fold in FCMs compared with NFMs. CTGF
(CCN2), a multi-functional growth factor that is up-regulated by TGFβ via AP-1 and SMADs
[28,56,57] was also increased in FCMs. CTGFmay act synergistically with TGFβ [28,56] and can
promote monocyte migration into the atherosclerotic plaque [58]. To validate our differential
gene expression data in vivo, we showed that CTGF staining in both FCM- and SMC-rich areas
of mouse plaques (Fig 6D). CTGF staining has also been reported in human atherosclerotic pla-
ques, particularly near areas associated with large numbers of macrophages e.g. the shoulder
region and surrounding the lipid core [58], and alveolar macrophages examined in vivo have
been shown to express CTGF [59]. On the other hand, thrombospondin-1, which is also impli-
cated in the binding and activation of TGFβ [31], was significantly decreased in FCMs.
TGFβ signalling is mediated by phosphorylation of SMADs, and by up-regulation of FOS,
JUN and LXR transcription factors [28,34,36,55,60,61]. Consistent with this, we found that
although the mRNA expression of SMADs 2 and 3 were not elevated in FCMs, levels of phos-
phorylated, nuclear localised SMAD2 were increased in granuloma FCMs relative to NFMs
and in plaque FCMs, suggesting that TGFβ1 signalling was occurring. SMAD2 staining has
been previously associated with FCMs in fibro-fatty lesions [60]. FCMs also had elevated
expression of FosB, JUN and JunB. Interestingly, other factors that are affected by the presence
of FosB, such as the extracellular matrix protein tenascin C [57], were also significantly up-reg-
ulated in our FCMs (S1 Table). We also confirmed that mouse FCMs overexpressed cFOS,
with protein expression often found in the nucleus.
Proteinases
Cathepsins C and E were overexpressed in in vivo generated FCMs in our study and also in
mouse BMDM loaded with acetylated LDL in vitro [44]. However, these are acidic proteases, and
only cathepsins with activity at neutral pH have been directly implicated in destabilization of pla-
ques [62,63]. We found increased expression of MMP2, which promotes SMCmigration and
proliferation [64]. MMP2 is also known to activate latent TGFβ [65] and release TGFβ from
extracellular matrix stores [55], which could further contribute to a pro-fibrotic action. MMP9,
which also promotes migration of SMC [64], was not changed in our study, despite data from
peritoneal FCMs showing a decrease [23]. Instead, we observed decreased expression of MMP13,
which is the main collagenase of mouse atherosclerosis [66]. On the other hand, the expression
of MMP23, which has not been studied in the context of atherosclerosis, was increased.
Polarization towards M1 or M2 phenotypes
Peritoneal FCMs appeared to be polarized away fromM1 compared to NFMs in LDL receptor
null mice [23]. Characteristic M1 genes, including IL1β and MMP9, were down-regulated and,
moreover, peritoneal FCMs were resistant to the M1 polarizing effects of added toll-like receptor
ligands ex vivo, in part because accumulation of desmosterol led to ligation of LXR, which stabi-
lized the co-repressor complex, NcoR [23]. In contrast with these results, we did not observe a
significant decrease in M1 marker genes, including MMP9, NOS2, CCL2, IL-6 and ARG2, in
granuloma FCMs compared with NFMs, although MMP13 and NF-κB1 levels, which are also
M1-related genes [24,37,38], were decreased. There could be several reasons for this discrep-
ancy, including different diets and background strains in the two studies and the metabolic con-
sequences of ApoE compared with LDL receptor knockout. Another difference is that we took
FCMs from subcutaneous granulomas rather than the peritoneum, and the cells therefore expe-
rienced a different inflammatory environment in vivo. NFMs from the peritoneum are known
to be strongly polarized towards M2 [67], whereas, given the foreign body reaction in granulo-
mas, it is not surprising that we measured considerable levels of M1 markers in both NFMs and
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FCMs (Table 4). Our previous work on subcutaneous granulomas in lipid- or chow-fed, wild-
type rabbits also demonstrated the presence of M1 markers, but these were greater in FCMs
than NFMs. FCMs had greater activation of NF-κB and up-regulation of the NF-κB dependent
genes, MMP1 andMMP3; they also had decreased expression of arginase-1 and increased nitrite
production compared with NFMs [21,22], confirming polarization away fromM2. In the only
available study of human plaque cells examined ex vivo, cells including FCMs also expressed M1
genes, and this was dependent on toll-like receptor-2 (TLR2) stimulation [68]. Hence M1/M2
polarisation appears to depend crucially on the microenvironment from which the FCMs are
obtained. FCMs appear polarised towards M1 when extracted from human plaques [68] and
rabbit granulomas [21,22], towards M2 when extracted from the peritoneum of LDL receptor
null mice [23] or neither M1 nor M2 when extracted frommouse subcutaneous granulomas in
this study. Consistent with this, FCMs bearing M1 markers, M2 markers or neither are detected
in mouse plaques by histology [69] and FCMs observed histologically in human plaques also
demonstrate a wide variety of phenotypes [9]. Many FCMs appear to be M1, based on nuclear
NF-κB localisation and expression of marker genes such as NOS2 and COX2 [8,19]. Laser cap-
ture dissected plaque macrophages also show up-regulation of several M1-related genes, includ-
ing NOS2, Arg2, TLR2 and IL1r1 [70]. However, FCMs bearing M2 markers such as CD206
and PPARγ [19] are also present, although they tend to be less foamy, probably thanks to up-
regulation of reverse transporters [13]. In plaques, FCMs may also ingest particles other than
LDLs, including bacteria, apoptotic bodies and cholesterol crystals that can cause additional
polarization towards M1 [71,72], or take up haem and become deactivated [16].
A similar disparity of findings has been obtained in in vitro studies, depending on the type
of lipid used (e.g. minimally compared to extensively oxidised LDL, acetylated LDL, oxidised
phospholipids or cholesterol, cholesterol crystals) and the phenotypic state of the mouse mac-
rophages before loading (reviewed by Adamson and Leitinger [46]). For example, ox-LDL
loading of M2 macrophages generates a pro-inflammatory state [50], but oxidised phospho-
lipid treatment leads to a distinct, anti-oxidant state [69]. Lipid ligands of PPARγ can prime
macrophages towards an anti-inflammatory state [13]. In agreement with this diversity of
responses, one study of ox-LDL loaded human monocyte derived macrophages observed over-
expression of M1 genes thanks to toll-like receptor activation [20] but another found little
effect on M1 or M2 markers, MMP-14 or TIMP-3, at least at the mRNA level [73], consistent
with our present findings.
Limitations of our study
Since FCMs and NFMs were both harvested from subcutaneous sponges in our study, the for-
eign body response to the sponge itself could not obscure the transcriptomic differences,
including up-regulation of pro-fibrotic genes, which we observed in FCMs. However, we do
not yet know how significantly these contribute to plaque progression and stability in man.
Supporting the relevance of our present data in mice, formation of human FCMs in vitro has
been previously shown to up-regulate expression of many of the same genes, including CTSC,
LXR, Cmpk2, and fibrotic genes [14,17,18,40,74]. Studies in human and mouse plaques,
including our own reported here, also corroborate the findings from isolated FCMs studied ex
vivo, but these have so far relied almost entirely on immunohistochemistry. In the future, it
would be desirable to confirm them with other methods such as transcriptomics of laser cap-
ture dissected plaque cells. However, this will not be an easy task, owing to the limited amounts
and quality of extracted RNA, the difficulties of extracting FCMs and NFMs from the same
microenvironments, and also of distinguishing macrophages from smooth muscle cells based
on CD68 staining [6].
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In addition, although our differential gene analysis implicated pro-fibrotic signalling path-
ways related to PDGF and TGFβ, their precise roles will require further verification. Macro-
phage-selective knockout of individual pro-fibrotic mediators and their receptors would shed
additional light but they are clearly beyond the present scope of this study. The translational
potential of our studies also needs further consideration. It will be interesting to investigate the
roles of the pro-fibrotic genes we identified in mice, using bio-bank and genetic approaches in
man. From a treatment perspective, selective oestrogen receptor modulators such as tamoxifen
that are known to increase active TGFβ levels in patients appear to stabilize plaques and reduce
acute coronary syndromes [75,76]. Based on our findings, further approaches, including target-
ing production of FOS and JUN transcription factors might represent alternative strategies.
Implications for plaque rupture
Our novel data show conclusively that FCMs overexpress mRNAs for collagen and other
matrix proteins that would tend to stabilize plaques. At first sight, this conclusion is paradoxi-
cal and needs to be reconciled with the more commonly-held view that FCMs overexpress
matrix-degrading enzymes and therefore promote collagen degradation and plaque rupture.
However, it is worth remembering that arterial fatty streaks and other xanthomas that contain
few VSMCs or fibroblasts neither rupture nor cause thrombosis. Our conclusion is, therefore,
that formation of FCMs is intrinsically pro-fibrotic and this may be necessary to stabilize early
lesions. FCMs in more advanced plaques, for example at the vulnerable shoulder regions of pla-
ques, are exposed to locally-acting inflammatory stimuli, which initiate other transcriptional
programmes that tip the balance from collagen synthesis to degradation and therefore promote
plaque rupture.
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